InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,617.63
(
0.04%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.70
(
-0.21%
)
Bitcoin
62,667.21
(
0.53%
)
Post# of 92948
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Wopsal101

Send PM Follow Ignore
Followers 4
Posts 316
Boards Moderated 0
Alias Born 02/09/2013

Wopsal101

Re: homeslice10 post# 78029

Saturday, 12/20/2014 12:29:09 PM

Saturday, December 20, 2014 12:29:09 PM

Post# of 92948
Nice post! One error though. SMD is a orphan designation and has 100 patients. The reason for this is an orphan designation is eligible for special pricing and government funding. It also has the most sites conducting trials, for the reasons stated above. Moving up the dates on AMD and lowering the number of patients to 45 was a very smart move because the company will not get any special rates for these trials.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up